Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study

BACKGROUND: In addition to achieving good glycemic control, diabetes care management aims to improve the quality of life (QOL) in patients. Treatment-associated difficulties and side effects frequently cause deterioration in QOL. Liraglutide, a GLP-1 receptor agonist, is a novel injection drug that...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Niiya, Tetsuji, Ono, Yasuhiro, Inaba, Naoyuki, Jinnouchi, Hideaki, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219656/
https://www.ncbi.nlm.nih.gov/pubmed/28074109
http://dx.doi.org/10.1186/s13098-016-0202-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219656/
https://www.ncbi.nlm.nih.gov/pubmed/28074109
http://dx.doi.org/10.1186/s13098-016-0202-0

Ejemplares similares